Dapagliflozin Reduces Hospitalizations in Patients With CKD Dapagliflozin Reduces Hospitalizations in Patients With CKD

Dapagliflozin reduced hospitalization for patients with CKD, a new study found, suggesting that dapagliflozin should be considered for treatment of these patients.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Internal Medicine News Source Type: news